---
layout: default
title: Publications
subtitle: Publications in Li Lab
permalink: /publication
---

# Pulications



## 2019



- Chen S, Li X. [Targeting EGFRvIII for treatment of glioblastoma: Frommolecular mechanisms to clinical strategies]. Zhong Nan Da Xue Xue Bao Yi XueBan. 2019 Nov 28;44(11):1281-1286. doi: 10.11817/j.issn.1672-7347.2019.180643.Chinese. PubMed PMID: 31919324.

   [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf) 



- Wang Y, Cheng T, Lu M, Mu Y, Li B, Li X, Zhan X. TMT-based quantitativeproteomics revealed follicle-stimulating hormone (FSH)-related molecularcharacterizations for potentially prognostic assessment and personalizedtreatment of FSH-positive non-functional pituitary adenomas. EPMA J. 2019 Aug29;10(4):395-414. doi: 10.1007/s13167-019-00187-w. eCollection 2019 Dec. PubMed PMID: 31832114; PubMed Central PMCID: PMC6882982.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf) 

- Dai S, Yan Y, Xu Z, Zeng S, Qian L, Huo L, Li X, Sun L, Gong Z. Corrigendum:SCD1 Confers Temozolomide Resistance to Human Glioma Cells Via theAkt/GSK3β/β-Catenin Signaling Axis. Front Pharmacol. 2019 Nov 15;10:1358. doi:10.3389/fphar.2019.01358. eCollection 2019. PubMed PMID: 31798454; PubMed CentralPMCID: PMC6874015.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Yan Y, Xu Z, Chen X, Wang X, Zeng S, Zhao Z, Qian L, Li Z, Wei J, Huo L, Li X,Gong Z, Sun L. Novel Function of lncRNA ADAMTS9-AS2 in Promoting TemozolomideResistance in Glioblastoma via Upregulating the FUS/MDM2 Ubiquitination Axis.Front Cell Dev Biol. 2019 Oct 2;7:217. doi: 10.3389/fcell.2019.00217. eCollection2019. PubMed PMID: 31632968; PubMed Central PMCID: PMC6783494.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Ye N, Jiang N, Feng C, Wang F, Zhang H, Bai HX, Yang L, Su Y, Huang C, WanggouS, Li X. Combined Therapy Sensitivity Index Based on a 13-Gene Signature PredictsPrognosis for IDH Wild-type and MGMT Promoter Unmethylated Glioblastoma Patients.J Cancer. 2019 Aug 29;10(22):5536-5548. doi: 10.7150/jca.30614. eCollection 2019.PubMed PMID: 31632497; PubMed Central PMCID: PMC6775685.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Cao H, Li X, Wang F, Zhang Y, Xiong Y, Yang Q. Phytochemical-Mediated GliomaTargeted Treatment: Drug Resistance and Novel Delivery Systems. Curr Med Chem.2019 Aug 9. doi: 10.2174/0929867326666190809221332. [Epub ahead of print] PubMed PMID: 31400262.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Yi X, Pei Q, Zhang Y, Zhu H, Wang Z, Chen C, Li Q, Long X, Tan F, Zhou Z, Liu W, Li C, Zhou Y, Song X, Li Y, Liao W, Li X, Sun L, Pei H, Zee C, Chen BT.MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy inLocally Advanced Rectal Cancer. Front Oncol. 2019 Jun 26;9:552. doi:10.3389/fonc.2019.00552. eCollection 2019. PubMed PMID: 31293979; PubMed Central PMCID: PMC6606732.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Qian S, Zhan X, Lu M, Li N, Long Y, Li X, Desiderio DM, Zhan X. QuantitativeAnalysis of Ubiquitinated Proteins in Human Pituitary and Pituitary AdenomaTissues. Front Endocrinol (Lausanne). 2019 May 22;10:328. doi:10.3389/fendo.2019.00328. eCollection 2019. PubMed PMID: 31191455; PubMed CentralPMCID: PMC6540463.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Chang K, Beers AL, Bai HX, Brown JM, Ly KI, Li X, Senders JT, Kavouridis VK,Boaro A, Su C, Bi WL, Rapalino O, Liao W, Shen Q, Zhou H, Xiao B, Wang Y, ZhangPJ, Pinho MC, Wen PY, Batchelor TT, Boxerman JL, Arnaout O, Rosen BR, GerstnerER, Yang L, Huang RY, Kalpathy-Cramer J. Automatic assessment of glioma burden: adeep learning algorithm for fully automated volumetric and bidimensionalmeasurement. Neuro Oncol. 2019 Nov 4;21(11):1412-1422. doi:10.1093/neuonc/noz106. PubMed PMID: 31190077; PubMed Central PMCID: PMC6827825.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Wu M, Li X, Liu Q, Xie Y, Yuan J, Wanggou S. miR-526b-3p serves as aprognostic factor and regulates the proliferation, invasion, and migration ofglioma through targeting WEE1. Cancer Manag Res. 2019 Apr 11;11:3099-3110. doi:10.2147/CMAR.S192361. eCollection 2019. PubMed PMID: 31114353; PubMed CentralPMCID: PMC6489667.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Xiong Y, Cao H, Zhang Y, Pan Z, Dong S, Wang G, Wang F, Li X.Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-BasedPopulation Study. World Neurosurg. 2019 Aug;128:e823-e834. doi:10.1016/j.wneu.2019.04.262. Epub 2019 May 13. PubMed PMID: 31096027.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Yang Q, Li X. Molecular Network Basis of Invasive Pituitary Adenoma: AReview. Front Endocrinol (Lausanne). 2019 Jan 24;10:7. doi:10.3389/fendo.2019.00007. eCollection 2019. Review. Erratum in: Front Endocrinol (Lausanne). 2019 Sep 24;10:657. PubMed PMID: 30733705; PubMed Central PMCID:PMC6353782.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

## 2018



- Yi X, Guan X, Zhang Y, Liu L, Long X, Yin H, Wang Z, Li X, Liao W, Chen BT,Zee C. Radiomics improves efficiency for differentiating subclinicalpheochromocytoma from lipid-poor adenoma: a predictive, preventive andpersonalized medical approach in adrenal incidentalomas. EPMA J. 2018 Sep21;9(4):421-429. doi: 10.1007/s13167-018-0149-3. eCollection 2018 Dec. PubMedPMID: 30538793; PubMed Central PMCID: PMC6261906.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Chen X, Wanggou S, Bodalia A, Zhu M, Dong W, Fan JJ, Yin WC, Min HK, Hu M,Draghici D, Dou W, Li F, Coutinho FJ, Whetstone H, Kushida MM, Dirks PB, Song Y, Hui CC, Sun Y, Wang LY, Li X, Huang X. A Feedforward Mechanism Mediated byMechanosensitive Ion Channel PIEZO1 and Tissue Mechanics Promotes GliomaAggression. Neuron. 2018 Nov 21;100(4):799-815.e7. doi:10.1016/j.neuron.2018.09.046. Epub 2018 Oct 18. PubMed PMID: 30344046.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Wang Z, Yi X, He J, Qing L, Zhou Z, Zhang Y, Zhu Z, Zhou C, Xie H, Li X, Zee C, Chen BT. Catheter-Based Computed Tomography Angiography in Anterolateral ThighPerforator Mapping of Chinese Patients. J Reconstr Microsurg. 2019Mar;35(3):221-228. doi: 10.1055/s-0038-1672129. Epub 2018 Oct 2. PubMed PMID:30278470.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Wu J, Kim C, Bai HX, Tang L, Wang Y, Li X, Zhang Z, Karakousis G, Huang R,Zhang PJ, Xiao B, Yang L. Comparison of Radiation Therapy Alone and Chemotherapy Alone for Low-Grade Gliomas without Surgical Resection. World Neurosurg. 2019Feb;122:e108-e120. doi: 10.1016/j.wneu.2018.09.109. Epub 2018 Sep 24. PubMedPMID: 30261385.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Xiao Y, Karam C, Yi J, Zhang L, Li X, Yoon D, Wang H, Dhakal K, Ramlow P, Yu T, Mo Z, Ma J, Zhou J. ROS-related mitochondrial dysfunction in skeletal muscleof an ALS mouse model during the disease progression. Pharmacol Res. 2018Dec;138:25-36. doi: 10.1016/j.phrs.2018.09.008. Epub 2018 Sep 18. PubMed PMID:30236524; PubMed Central PMCID: PMC6263743.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Qian S, Yang Y, Li N, Cheng T, Wang X, Liu J, Li X, Desiderio DM, Zhan X.Prolactin Variants in Human Pituitaries and Pituitary Adenomas Identified WithTwo-Dimensional Gel Electrophoresis and Mass Spectrometry. Front Endocrinol(Lausanne). 2018 Aug 28;9:468. doi: 10.3389/fendo.2018.00468. eCollection 2018.PubMed PMID: 30210449; PubMed Central PMCID: PMC6121189.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Sang S, Wanggou S, Wang Z, Lin X, Jiang N, Ye N, Li X. Clinical Long-TermFollow-Up Evaluation of Functional Neuronavigation in Adult Cerebral Gliomas.World Neurosurg. 2018 Nov;119:e262-e271. doi: 10.1016/j.wneu.2018.07.127. Epub2018 Jul 25. PubMed PMID: 30053568.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Huang Y, Chan L, Bai HX, Li X, Zhang Z, Wang Y, Cao Y, Karakousis G, Huang R,Xiao B, Zhang PJ, Yang L. Assessment of care pattern and outcome inhemangioblastoma. Sci Rep. 2018 Jul 24;8(1):11144. doi:10.1038/s41598-018-29047-9. PubMed PMID: 30042517; PubMed Central PMCID:PMC6057968.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Zou Y, Neale N, Sun J, Yang M, Bai HX, Tang L, Zhang Z, Landi A, Wang Y,Huang RY, Zhang PJ, Li X, Xiao B, Yang L. Prognostic Factors in Clival Chordomas:An Integrated Analysis of 347 Patients. World Neurosurg. 2018 Oct;118:e375-e387. doi: 10.1016/j.wneu.2018.06.194. Epub 2018 Jun 30. PubMed PMID: 29969746.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Yi X, Cao H, Tang H, Gong G, Hu Z, Liao W, Sun L, Chen BT, Li X. Gliosarcoma:a clinical and radiological analysis of 48 cases. Eur Radiol. 2019Jan;29(1):429-438. doi: 10.1007/s00330-018-5398-y. Epub 2018 Jun 12. PubMed PMID:29948068.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Tang L, Deng L, Bai HX, Sun J, Neale N, Wu J, Wang Y, Chang K, Huang RY,Zhang PJ, Li X, Xiao B, Cao Y, Tao Y, Yang L. Reduced expression of DNA repairgenes and chemosensitivity in 1p19q codeleted lower-grade gliomas. J Neurooncol. 2018 Sep;139(3):563-571. doi: 10.1007/s11060-018-2915-4. Epub 2018 Jun 19. PubMedPMID: 29923053; PubMed Central PMCID: PMC6697086.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Ma X, Jin Y, Wang Y, Zhang S, Peng D, Yang X, Wei S, Chai W, Li X, Tian J.Multimodality Molecular Imaging-Guided Tumor Border Delineation and Photothermal Therapy Analysis Based on Graphene Oxide-Conjugated Gold Nanoparticles Chelatedwith Gd. Contrast Media Mol Imaging. 2018 May 7;2018:9321862. doi:10.1155/2018/9321862. eCollection 2018. PubMed PMID: 29853812; PubMed CentralPMCID: PMC5964426.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Li X, Cao H, Liu Y. Genetic epidemiology and risk factors for brain tumors.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Apr 28;43(4):345-353. doi:10.11817/j.issn.1672-7347.2018.04.003. PubMed PMID: 29774869.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)



## 2017

 

- Zeng J, Liu H, Liu L, Liao W, Hu P, Wang X, Li X, Sun L, Zhang Y, Yi X.Fibrosarcoma arising in the paranasal sinus: a clinicopathological andradiological analysis. Dentomaxillofac Radiol. 2018 Jul;47(6):20170459. doi:10.1259/dmfr.20170459. Epub 2018 Apr 23. PubMed PMID: 29658783; PubMed CentralPMCID: PMC6196049.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Ye B, Stary CM, Li X, Gao Q, Kang C, Xiong X. Engineering chimeric antigenreceptor-T cells for cancer treatment. Mol Cancer. 2018 Feb 15;17(1):32. doi:10.1186/s12943-018-0814-0. Review. PubMed PMID: 29448937; PubMed Central PMCID:PMC5815249.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Wu J, Neale N, Huang Y, Bai HX, Li X, Zhang Z, Karakousis G, Huang R, ZhangPJ, Tang L, Xiao B, Yang L. Comparison of Adjuvant Radiation Therapy Alone andChemotherapy Alone in Surgically Resected Low-Grade Gliomas: Survival Analyses of2253 Cases from the National Cancer Data Base. World Neurosurg. 2018Apr;112:e812-e822. doi: 10.1016/j.wneu.2018.01.163. Epub 2018 Jan 31. PubMedPMID: 29409888.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Dai S, Yan Y, Xu Z, Zeng S, Qian L, Huo L, Li X, Sun L, Gong Z. SCD1 Confers Temozolomide Resistance to Human Glioma Cells via the Akt/GSK3β/β-CateninSignaling Axis. Front Pharmacol. 2018 Jan 4;8:960. doi: 10.3389/fphar.2017.00960.eCollection 2017. Erratum in: Front Pharmacol. 2019 Nov 15;10:1358. PubMed PMID: 29354058; PubMed Central PMCID: PMC5758607.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Chang K, Bai HX, Zhou H, Su C, Bi WL, Agbodza E, Kavouridis VK, Senders JT,Boaro A, Beers A, Zhang B, Capellini A, Liao W, Shen Q, Li X, Xiao B, Cryan J,Ramkissoon S, Ramkissoon L, Ligon K, Wen PY, Bindra RS, Woo J, Arnaout O,Gerstner ER, Zhang PJ, Rosen BR, Yang L, Huang RY, Kalpathy-Cramer J. ResidualConvolutional Neural Network for the Determination of IDH Status in Low- andHigh-Grade Gliomas from MR Imaging. Clin Cancer Res. 2018 Mar 1;24(5):1073-1081. doi: 10.1158/1078-0432.CCR-17-2236. Epub 2017 Nov 22. PubMed PMID: 29167275;PubMed Central PMCID: PMC6051535.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Zou Y, Sun J, Zhou Y, Bai HX, Huang X, Babu R, Landi A, Foong KS, Zhang Z,Woo JH, Tao Y, Li X, Tang X, Xiao B, Zhang PJ, Yang L. Prognostic Factors andTreatment of Spinal Astrocytomas: A Multi-institutional Cohort Analysis. Spine(Phila Pa 1976). 2018 May 15;43(10):E565-E573. doi: 10.1097/BRS.0000000000002485.PubMed PMID: 29135884.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Wu J, Zou T, Bai HX, Li X, Zhang Z, Xiao B, Nasrallah M, Karakousis G, Cao Y,Zhang PJ, Yang L. Comparison of chemoradiotherapy with radiotherapy alone for"biopsy only" anaplastic astrocytoma. Oncotarget. 2017 Apr 26;8(40):69038-69046. doi: 10.18632/oncotarget.17441. eCollection 2017 Sep 15. PubMed PMID: 28978179;PubMed Central PMCID: PMC5620319.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Cao H, Wang F, Li XJ. Future Strategies on Glioma Research: From Big Data to the Clinic. Genomics Proteomics Bioinformatics. 2017 Aug;15(4):263-265. doi:10.1016/j.gpb.2017.07.001. Epub 2017 Aug 7. PubMed PMID: 28797870; PubMed CentralPMCID: PMC5582798.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Wu M, Wanggou S, Li X, Liu Q, Xie Y. Overexpression of mitochondrial serinehydroxyl-methyltransferase 2 is associated with poor prognosis and promotes cell proliferation and invasion in gliomas. Onco Targets Ther. 2017 Jul27;10:3781-3788. doi: 10.2147/OTT.S130409. eCollection 2017. PubMed PMID:28794642; PubMed Central PMCID: PMC5538688.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Xie Y, Wanggou S, Liu Q, Li X, Liu J, Wu M. A brain-specific isoform ofapoptosis-inducing factor 2 attenuates ischemia-induced oxidative stress in HT22 cells. Neurochem Int. 2018 Jan;112:179-186. doi: 10.1016/j.neuint.2017.07.006.Epub 2017 Jul 18. PubMed PMID: 28732772.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Yi X, Xiao D, He Y, Yin H, Gong G, Long X, Liao W, Li X, Sun L, Zhang Y,Zhang B. Spinal Solitary Fibrous Tumor/Hemangiopericytoma: A Clinicopathologicand Radiologic Analysis of Eleven Cases. World Neurosurg. 2017 Aug;104:318-329.doi: 10.1016/j.wneu.2017.05.016. Epub 2017 May 13. PubMed PMID: 28512044.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Jiang N, Wang Z, Chen W, Xie Y, Peng Z, Yuan J, Wanggou S, Su Y, Li X, YuanX. Microsurgical Outcomes After Gross Total Resection on Vestibular Schwannoma inElderly Patients: A Matched Cohort Study. World Neurosurg. 2017 May;101:457-465. doi: 10.1016/j.wneu.2017.01.120. Epub 2017 Feb 9. PubMed PMID: 28192265.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

## 2016



- Xiong T, Wanggou S, Li X, Liu Q, Jiang X, Peng Z, Yuan X. [Influence ofpreventive use of vasopressin tannate on diabetes insipidus and serum sodium atthe early postoperation of craniopharyngioma]. Zhong Nan Da Xue Xue Bao Yi XueBan. 2016 Oct 28;41(10):1058-1063. Chinese. PubMed PMID: 27807328.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)

 

- Wang FY, Kang CS, Wang-Gou SY, Huang CH, Feng CY, Li XJ. EGFL7 is anintercellular EGFR signal messenger that plays an oncogenic role in glioma.Cancer Lett. 2017 Jan 1;384:9-18. doi: 10.1016/j.canlet.2016.10.009. Epub 2016Oct 8. PubMed PMID: 27725228.

  [[Abstract]](https://pubmed.ncbi.nlm.nih.gov/31919324/)     [[Full Paper]](/resources/publications/Li_GenProBio_2020.pdf)